A biomarker panel for IPF may identify RA patients at higher risk for ILD, supporting biological overlap between IPF and ...

Mortality rates for pneumonia and pulmonary fibrosis have declined since 1999, but disparities persist by sex, race, and ...

Individuals diagnosed with chronic spontaneous urticaria (CSU) are at a moderately increased risk of multiple cardiovascular ...

Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical ...

Nicoletta Colombo, MD, PhD, of the University of Milan-Bicocca, discussed the rationale behind paclitaxel with bevacizumab ...

When families come into the clinic, there is a lot of hand-holding, Spizuoco said, to explain the treatments. She recommends ...

Both children and adults can injure their eyes through a bad fall or getting hit in the eye, making awareness of surroundings ...

Access to glucagon-like peptide-1 (GLP-1) receptor agonists for obesity treatment could be expanded through innovative ...

By collaborating with patients from the very start and respecting their unique perspectives, decision-makers can create a ...

Panelists discuss how new dual-targeting agents and TKIs are redefining treatment approaches in EGFR-positive NSCLC.

A new study 1 found that the use of stereotactic body radiation therapy (SBRT) produced similar overall survival in patients ...

Aggressive lifestyle and risk factor control after ablation significantly lowers atrial fibrillation recurrence and improves ...